Person profile
Roles
Address
Novato, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ultragenyx Pharmaceutical Inc.
20 Jun 24
4
Neumora Therapeutics, Inc.
14 Jun 24
4
Crinetics Pharmaceuticals, Inc.
11 Jun 24
4
Atara Biotherapeutics, Inc.
2 Apr 24
4
Crinetics Pharmaceuticals, Inc.
22 Mar 24
144
Crinetics Pharmaceuticals, Inc.
20 Mar 24
4
Ultragenyx Pharmaceutical Inc.
11 Mar 24
144
Ultragenyx Pharmaceutical Inc.
7 Mar 24
4
Neumora Therapeutics, Inc.
18 Sep 23
3
Neumora Therapeutics, Inc.
14 Sep 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jun 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 5,345 | 0.00 | 20,205 |
18 Jun 24 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 37.42 | 9,900 | 370.46 k | 9,900 |
13 Jun 24 | NMRA Neumora Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,100 | 0.00 | 20,100 |
13 Jun 24 | NMRA Neumora Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.95 | 28,571 | 284.28 k | 28,571 |
7 Jun 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,400 | 0.00 | 21,936 |
7 Jun 24 | CRNX Crinetics Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 44.71 | 12,500 | 558.88 k | 12,500 |
31 Mar 24 | ATRA Atara Biotherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 150,000 | 0.00 | 259,000 |
20 Mar 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 45.5 | 17,500 | 796.25 k | 18,536 |
20 Mar 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 18.29 | 17,500 | 320.08 k | 36,036 |
20 Mar 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 43.58 | 17,500 | 762.65 k | 18,536 |